Market OverviewRegional dynamics are shaping strategic priorities across the Genitourinary Drugs Market. Valued at 20.81 USD billion in 2024, the market is projected to reach 36.36 USD billion by 2035 at a 5.16% CAGR, with adoption patterns diverging sharply between established and emerging regions. Comprehensive regional opportunity mapping. Current Market LandscapeNorth America remains the...